Biologics Analytical Services

Catalent offers one of the most extensive selections of analytical services within the large molecule landscape. Possessing a distinguished track record exceeding three decades, we boast a vast repertoire of analytical methods developed and implemented for a diverse clientele in the biologics sector. Catalent's customizable and independent analytical solutions encompass the entirety of the drug development process, from pre-clinical assessments to post-approval release and stability testing.

Our service portfolio caters to traditional biologics alongside cutting-edge therapies, including antibody-drug conjugates, cell and gene therapies, and mRNA vaccines. The analytical expertise extends to drug substance, drug product, and intermediate stages, all conducted at Catalent's specialized biologics analytical facilities within the United States. By leveraging our extensive experience and comprehensive capabilities, we foster a collaborative environment, developing and implementing innovative analytical methods to efficiently and reliably address the testing needs of our partners, irrespective of the development phase or scale of the project.